Ambiq Micro (NYSE: AMBQ) announced the closing of its upsized underwritten public offering of 2.3 million shares of common stock, including the full exercise of the underwriters' option to purchase an additional 300,000 shares, at a public offering price of $78.00 per share. The offering generated gross proceeds of approximately $179.4 million before underwriting discounts, commissions and offering expenses. This capital raise underscores investor confidence in Ambiq's mission to enable intelligence everywhere through its ultra-low-power semiconductor technology.
BofA Securities and UBS Investment Bank served as joint lead book-running managers for the offering, while Needham & Company, Stifel and Roth Capital Partners acted as joint book-running managers. The offering was completed pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission. The full press release is available at https://ibn.fm/ZgIHv.
Headquartered in Austin, Texas, Ambiq's mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Ambiq enables its customers to deliver AI compute at the edge where power consumption challenges are the most severe. Ambiq's technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. Ambiq has powered over 300 million devices to date.
The successful offering provides Ambiq with substantial capital to accelerate its growth, expand its product portfolio, and strengthen its position in the low-power semiconductor market. With the increasing demand for AI at the edge, Ambiq's technology is critical for enabling battery-powered devices to perform complex computations without compromising battery life. This funding will likely support further research and development, as well as potential strategic acquisitions to enhance its technology platform.
For more information about Ambiq, visit https://ambiq.com/.
